OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 68 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,205 | +237.0% | 1,636 | +146.4% | 0.00% | – |
| Q2 2023 | $5,996 | +28.6% | 664 | -50.6% | 0.00% | – |
| Q1 2023 | $4,664 | +173.4% | 1,344 | +93.1% | 0.00% | – |
| Q4 2022 | $1,706 | +70.6% | 696 | +96.6% | 0.00% | – |
| Q3 2022 | $1,000 | -93.8% | 354 | -91.0% | 0.00% | – |
| Q2 2022 | $16,000 | -96.5% | 3,933 | -96.4% | 0.00% | – |
| Q1 2022 | $463,000 | -91.2% | 108,645 | -80.7% | 0.00% | – |
| Q4 2021 | $5,268,000 | -68.5% | 562,854 | -7.3% | 0.00% | -100.0% |
| Q3 2021 | $16,730,000 | -7.0% | 607,051 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $17,984,000 | -17.0% | 642,751 | -1.5% | 0.00% | -50.0% |
| Q1 2021 | $21,656,000 | -31.2% | 652,697 | -0.3% | 0.00% | -33.3% |
| Q4 2020 | $31,468,000 | – | 654,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |